Influence of Simple Renal Cysts on Renal Function

Sponsor
Moscow State University of Medicine and Dentistry (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05134077
Collaborator
(none)
120
2
2.4

Study Details

Study Description

Brief Summary

This is a prospective, cohort, randomized clinical trial examining the effect of simple renal cysts on renal function.

Condition or Disease Intervention/Treatment Phase
  • Procedure: CT scan with contrast
  • Radiation: Nephroscintigraphy
N/A

Detailed Description

This study is planned to include patients from S.I. Spasokukotskiy Citi Clinical Hospital with simple renal accidentally discovered cyst.

The aim of the study is to evaluate the impact of simple renal cysts on renal function and explore the correlation between cyst's size, parenchymal atrophy, and renal function.

After receiving the results, the analysis of the data obtained is carried out.

  1. The symmetry of the function of both kidneys is analyzed

  2. The relationship between the presence of a simple kidney cyst and a decrease in its function in comparison with a healthy kidney is analyzed.

  3. The relationship between the maximum size of a kidney cyst and a decrease in its function in comparison with a healthy kidney is analyzed.

  4. The relationship between the volume of the atrophied kidney parenchyma and a decrease in its function as compared with a healthy kidney is analyzed.

  5. Correspondence of GFR indices obtained by scintigraphy and by calculation using the Schwartz formula

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
We present a cohort study of patients with renal cysts (the first group - kidneys with cysts, the second group - kidneys without cysts in the studied patients). All patients will undergo contrast-enhanced CT of the urinary system (volume of atrophic parenchyma will be calculated), as well as nephroscintigraphy.We present a cohort study of patients with renal cysts (the first group - kidneys with cysts, the second group - kidneys without cysts in the studied patients). All patients will undergo contrast-enhanced CT of the urinary system (volume of atrophic parenchyma will be calculated), as well as nephroscintigraphy.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Influence of Simple Renal Cysts on Renal Function: Cohort Clinical Trial.
Anticipated Study Start Date :
Feb 16, 2022
Anticipated Primary Completion Date :
Mar 8, 2022
Anticipated Study Completion Date :
May 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: kidneys with simple cysts

Patients involve from Citi Clinical Hospital with simple renal accidentally discovered cyst.

Procedure: CT scan with contrast
CT scan with contrast is necessary to determine the position of renal cysts, their location, and size (determine volume of atrophic parenchyma will be calculated).

Radiation: Nephroscintigraphy
Nephroscintigraphy is necessary to determine the renal function

Active Comparator: contralateral kidneys without cyst

Рatients involve from Citi Clinical Hospital with simple renal accidentally discovered cyst.

Procedure: CT scan with contrast
CT scan with contrast is necessary to determine the position of renal cysts, their location, and size (determine volume of atrophic parenchyma will be calculated).

Radiation: Nephroscintigraphy
Nephroscintigraphy is necessary to determine the renal function

Outcome Measures

Primary Outcome Measures

  1. Renal function [1 month]

    Glomerular filtration rate (GFR, ml/min/1.73 m2) is a test used to check how well the kidneys are working. Specifically, it estimates how much blood passes through the glomeruli each minute. A GFR of 60 or higher is in the normal range. A GFR below 60 may mean kidney disease. A GFR of 15 or lower may mean kidney failure. The measurement of the glomerular filtration rate will be measured according to the results of the blood test and the results of nephroscintigraphy

Secondary Outcome Measures

  1. Ratio of cyst size and volume of atrophic renal parenchyma [1 month]

    Computed tomography with contrast will be used to determine the position of renal cysts, their location, size and volume of atrophic parenchyma (cm2) are calculated

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients with simple kidney cyst Bosniak 1-2

  • Normal blood creatinine values

Exclusion Criteria:
  • Impossibility of performing CT with intravenous contrast enhancement.

  • Bosniak 3-4

  • CKD

  • Bilateral cysts

  • Multiple renal cysts

  • Sinus cysts

  • Cysts with a max size less than 2 cm.

  • Single kidney

  • Chronic kidney disease and conditions associated with the potential decrease of kidney function

  • Glomerulonephritis

  • Chronic pyelonephritis

  • Amyloidosis

  • Diabetes

  • Autoimmune diseases

  • Urolithiasis

  • Kidney and upper urinary tract surgery

  • Anomalies of the kidneys and upper urinary tract with impaired outflow

  • Calcification of the renal arteries

  • Renal artery stenosis

  • Hypertensive nephropathy

  • Severe concomitant diseases requiring

  • Chemotherapy

  • Long-term (more than 10 days) antibiotic therapy in the last month

  • Long-term (more than 7 days) use of NSAIDs in the last month

  • Diagnostic and therapeutic manipulations accompanied by the introduction of X-ray contrast agents

  • Secondarily shriveled or non-functioning kidney

  • Kidney hypoplasia

  • Accessory kidney

  • a decrease in GFR below normal values for a kidney without a cyst (as determined by nephroscintigraphy)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Moscow State University of Medicine and Dentistry

Investigators

  • Principal Investigator: Tukhtasin Mahmudov, Moscow state university of medicine and dentistry named after A.I. Evdokimov

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Moscow State University of Medicine and Dentistry
ClinicalTrials.gov Identifier:
NCT05134077
Other Study ID Numbers:
  • SRC
First Posted:
Nov 24, 2021
Last Update Posted:
Nov 24, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Moscow State University of Medicine and Dentistry
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 24, 2021